Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal alloimmune thrombocytopenia.

Sandra Rothenberger1

  • 1Department of Pathology, Indiana University Hospital, Indianapolis, Indiana 46202, USA.

Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|March 12, 2002
PubMed
Summary

Neonatal alloimmune thrombocytopenia (NAIT) arises from maternal immunization to fetal platelet antigens. Early diagnosis and platelet transfusion are crucial for preventing severe bleeds in affected newborns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prosthetic reconstruction of a patient with an acquired nasal defect using extraoral implants and a CAD/CAM copy-milled bar.

Journal of prosthodontics : official journal of the American College of Prosthodontists·2014
See all related articles

Area of Science:

  • Immunology
  • Hematology
  • Neonatology

Background:

  • Neonatal alloimmune thrombocytopenia (NAIT) is an immune condition where maternal antibodies target fetal platelet antigens.
  • This can lead to severe thrombocytopenia in newborns, increasing the risk of intracranial hemorrhage.
  • The Human Platelet Antigen (HPA) system, particularly HPA-1a, is a common cause of NAIT.

Purpose of the Study:

  • To review the pathophysiology, clinical manifestations, and management strategies for NAIT.
  • To present clinical experience with the treatment of neonates diagnosed with NAIT.

Main Methods:

  • Literature review on NAIT pathophysiology, clinical features, and treatment.
  • Retrospective analysis of cases treated for NAIT.

Related Experiment Videos

Main Results:

  • NAIT is caused by maternal alloimmunization against fetal platelet-specific antigens.
  • HPA-1a incompatibility is the most frequent cause of NAIT.
  • Intracranial hemorrhage is a significant risk in affected neonates.

Conclusions:

  • Prompt diagnosis and intervention, including platelet transfusion, are vital for managing NAIT.
  • Understanding NAIT's mechanisms and clinical course is essential for optimal neonatal care.